Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $29.4200 (-1.08%) ($28.8200 - $30.5100) on Wed. Aug. 1, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.29% (three month average) | RSI | 19 | Latest Price | $29.4200(-1.08%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.6% a day on average for past five trading days. | Weekly Trend | EDIT declines -9.5% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(62%) XBI(61%) IWO(59%) ARKK(57%) | Factors Impacting EDIT price | EDIT will decline at least -1.645% in a week (0% probabilities). VXX(-13%) VIXM(-12%) TLT(-5%) GDXJ(-5%) SHY(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.645% (StdDev 3.29%) | Hourly BBV | 0 () | Intraday Trend | -0.8% | | | |
|
1 - 5 Day Possible Target | $14.41(-51.02%) | Resistance Level | $34.5 | 5 Day Moving Average | $29.96(-1.8%) | 10 Day Moving Average | $32.03(-8.15%) | 20 Day Moving Average | $34.5(-14.72%) | To recent high | -28.3% | To recent low | 0% | Market Cap | $1.827b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |